These hub genes —key regulators of cytoskeletal dynamics and cell migration—implies that LSM2 may promote glioma progression by dysregulating these effector molecules, potentially via aberrant splicing of their pre-mRNAs. The gene discussed is LSM2; the disease is glioma.